Mostrar el registro sencillo de la publicación

dc.contributor.authorSapunar, Jorge
dc.contributor.authorEscalona, Alex
dc.contributor.authorAraya, A. Verónica
dc.contributor.authorAylwin, Carmen G.
dc.contributor.authorBastías, María J.
dc.contributor.authorBoza, Camilo
dc.contributor.authorCárcamo, Carlos
dc.contributor.authorCsendes, Attila
dc.contributor.authorDavidof, Patricio
dc.contributor.authorFunke, Ricardo
dc.contributor.authorGómez, Patricia
dc.contributor.authorGonzález, María I.
dc.contributor.authorLahsen, Rodolfo
dc.contributor.authorLanzarini, Enrique
dc.contributor.authorMaíz, Alberto
dc.contributor.authorMujica-Escudero, Verónica
dc.contributor.authorMuñoz, Rodrigo
dc.contributor.authorPérez, Gustavo
dc.contributor.authorRaimann, Félix
dc.contributor.authorSalman, Patricio
dc.contributor.authorSepúlveda, Matías
dc.contributor.authorSoto, Néstor
dc.contributor.authorVillagrán, Rodrigo
dc.date.accessioned2022-11-29T12:24:03Z
dc.date.available2022-11-29T12:24:03Z
dc.date.issued2018
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/4176
dc.description.abstractDiabetes Mellitus (DM) and obesity are a public health problem in Chile. Bariatric surgery is the most effective treatment alternative to achieve a significant and sustained weight reduction in patients with morbid obesity. The results of controlled clinical trials indicate that, compared to medical treatment, surgery for obese patients with DM2 allows a better control of blood glucose and cardiovascular risk factors, reduces the need for medications and increases the likelihood for remission. Consensus conferences and clinical practice guidelines support bariatric surgery as an option to treat DM2 in Class III Obesity (Body Mass Index (BMI) > 40) regardless of the glycemic control and the complexity of pharmacological treatment and in Class II Obesity (BMI 35-39,9) with inadequate glycemic control despite optimal pharmacological treatment and lifestyle. However, surgical indication for patients with DM2 and BMI between 30-34.9, the most prevalent sub-group, is only suggested. The Chilean Societies of Endocrinology and Diabetes and of Bariatric and Metabolic Surgery decided to generate a consensus regarding the importance of other factors related to DM2 that would allow a better selection of candidates for surgery, particularly when weight does not constitute an indication. Considering the national reality, we also need a statement regarding the selection and characteristics of the surgical procedure as well as the role of the diabetologist in the multidisciplinary team.es_CL
dc.language.isoeses_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceRevista Médica de Chile, 146(10), 1175-1183es_CL
dc.subjectBariatric surgeryes_CL
dc.subjectConsensuses_CL
dc.subjectDiabetes mellituses_CL
dc.subjectType 2es_CL
dc.titleRol de la cirugía bariátrica/metabólica en el manejo de la diabetes mellitus 2. Consenso SOCHED/SCCBMes_CL
dc.title.alternativeConsensus statement of the chilean endocrinological society on the role of bariatric surgery in type 2 diabeteses_CL
dc.typeArticlees_CL
dc.ucm.facultadFacultad de Medicinaes_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.indexacionScieloes_CL
dc.ucm.uriwww.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001001175&lng=en&nrm=iso&tlng=enes_CL
dc.ucm.doidoi.org/10.4067/S0034-98872018001001175es_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile